← FDA Drug Approvals (Drugs@FDA)

ACETYLCYSTEINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SOMERSET THERAPS LLC · Approved 2024-06-07

Drug application

FDA Application #

ANDA218397

Application type

Abbreviated New Drug Application (Generic)

Brand name

ACETYLCYSTEINE

Generic name

ACETYLCYSTEINE

Active ingredients

ACETYLCYSTEINE

Dosage form

INJECTABLE

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

SOMERSET THERAPS LLC

Manufacturer

Somerset Therapeutics, LLC

First approval

2024-06-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown